ArticleArchives of virology2026

A novel molecule inhibits SARS-CoV-2 RBD binding to the ACE2 receptor, blocks viral entry and exhibits antiviral activity in a murine model.

Sanketkumar Nehul et al.PubMed ↗Publisher ↗

No numbers read from the abstract.